CORRELATIONS HELICOBACTER-PYLORI STOOL ANTIGEN AND ENDOSCOPIC FINDINGS IN PATIENTS WITH PERSISTENT UPPER ABDOMINAL COMPLAINTS

Document Type : Original Article

Authors

Department of Hepatology and Gastroenterology National Liver Institute- Menoufia University

Abstract

Background: Helicobacter pylori (H. pylori) is of major concern today because of its causal relationship with gastro duodenal disease. One half of the world’s population has H. pylori infection, with an estimated prevalence of more than 90% in developing countries. Dyspepsia is a prevalent complaint in general practice and gastrointestinal clinics. Since its discovery and H. pylori was attributed for being responsible for many of upper GIT symptoms. The gold standard test for diagnosis is the upper GIT endoscopy with biopsy, however it isn’t available not in all health care facilities beside its invasive nature which is not accepted by many patients.
Objective: The aim of this study was to compare the diagnostic accuracy of H. pylori antigen in stool with endoscopic finding in patients with upper abdominal symptoms.
Patients and methods: This study included 150 with upper abdominal complaints referred from outpatient as well as inpatient department who had undergone gastric biopsy during upper GI endoscopy for various dyspeptic symptoms. The cases were recruited from Liver Institute, Al Mahalla Al Kobra, Gharbia Governerate, Egypt.
Results: Regarding the presenting symptoms, the most common presenting symptom was dyspepsia (53 cases – 39.3%), followed by epigastric pain (53 cases – 35.5%). Abdominal fullness was reported in 15 cases (10%). Stool antigen test was positive in 91 cases (60.7%). Moreover, campylobacter-like organism (CLO) test was positive in 98 cases (65.3%). Endoscopy revealed no abnormality in 29 cases (19.3%). The most common encountered finding was mosaic antral appearance. Antral erosions were diagnosed in 15 cases (10%) whereas erosive gastritis was present in 13 cases (8.6%). Biopsy findings were positive in 115 (76.7%) cases and negative in 35 (23.3%) cases. As compared with results of biopsies, stool antigen test revealed 77.8% sensitivity, 90% specificity and total validity of 85%, with high significant level of agreement between the two techniques.
Conclusion: Dyspepsia is the common presentation among cases complaining from upper GIT symptoms. Stool antigen test for H. Pylori revealed high sensitivity in comparison with histopathological findings in diagnosis cases with upper GIT symptoms.

Keywords

Main Subjects


CORRELATIONS HELICOBACTER-PYLORI STOOL ANTIGEN AND ENDOSCOPIC FINDINGS IN PATIENTS WITH PERSISTENT UPPER ABDOMINAL COMPLAINTS

By

Yasser Abou El-Soud Mohammed, Eman Ahmed Rewisha, El-Sayed Tharwa and Mahmoud Helmy Allam

Department of Hepatology and Gastroenterology National Liver Institute- Menoufia University

Corresponding author: Yasser Abou El-Soud Mohammed,

E-mail: yasser-abouelsoud2326@gmail.com

ABSTRACT

Background: Helicobacter pylori (H. pylori) is of major concern today because of its causal relationship with gastro duodenal disease. One half of the world’s population has H. pylori infection, with an estimated prevalence of more than 90% in developing countries. Dyspepsia is a prevalent complaint in general practice and gastrointestinal clinics. Since its discovery and H. pylori was attributed for being responsible for many of upper GIT symptoms. The gold standard test for diagnosis is the upper GIT endoscopy with biopsy, however it isn’t available not in all health care facilities beside its invasive nature which is not accepted by many patients.

Objective: The aim of this study was to compare the diagnostic accuracy of H. pylori antigen in stool with endoscopic finding in patients with upper abdominal symptoms.

Patients and methods: This study included 150 with upper abdominal complaints referred from outpatient as well as inpatient department who had undergone gastric biopsy during upper GI endoscopy for various dyspeptic symptoms. The cases were recruited from Liver Institute, Al Mahalla Al Kobra, Gharbia Governerate, Egypt.

Results: Regarding the presenting symptoms, the most common presenting symptom was dyspepsia (53 cases – 39.3%), followed by epigastric pain (53 cases – 35.5%). Abdominal fullness was reported in 15 cases (10%). Stool antigen test was positive in 91 cases (60.7%). Moreover, campylobacter-like organism (CLO) test was positive in 98 cases (65.3%). Endoscopy revealed no abnormality in 29 cases (19.3%). The most common encountered finding was mosaic antral appearance. Antral erosions were diagnosed in 15 cases (10%) whereas erosive gastritis was present in 13 cases (8.6%). Biopsy findings were positive in 115 (76.7%) cases and negative in 35 (23.3%) cases. As compared with results of biopsies, stool antigen test revealed 77.8% sensitivity, 90% specificity and total validity of 85%, with high significant level of agreement between the two techniques.

Conclusion: Dyspepsia is the common presentation among cases complaining from upper GIT symptoms. Stool antigen test for H. Pylori revealed high sensitivity in comparison with histopathological findings in diagnosis cases with upper GIT symptoms.

Keywords: Helicobacter-Pylori, Stool Antigen, Endoscopic Findings, Upper Abdominal.

 

 

 

 

INTRODUCTION

     Gastrointestinal symptoms are highly prevalent in the general population. Dyspepsia is the most common upper gastrointestinal symptom complex with 25% of the general population suffering from dyspeptic symptoms and has great socio-economic impact (Talley, 2017). The causes of dyspepsia remain uncertain and are likely to be infectious and non-infectious agents (Riddle et al., 2016).

     Upper GI symptoms like dyspepsia, heartburn, pain abdomen and hematemesis are some of the common complaints with which patients present to the medical outpatient clinics. It impairs the quality of life and adds to the financial burden due to repeated hospital visits and medications (Srinivasan et al., 2016).

     Helicobacter pylori infection is the most common chronic bacterial infection in the world. This bacterium colonizes human gastric mucosa and can elicit lifelong inflammatory and immune responses, with release of various bacterial and host dependent cytotoxic substances. It causes chronic and active gastritis, peptic ulcer disease and associated with increased risk of developing gastric cancer (Diaconu et al., 2017).

     In a setting where access to upper GI endoscopy is difficult or unaffordable or if the prevalence is high, it is very important for clinicians to know common causes of dyspepsia and frequency of H. pylori infection to recommend empirical eradication can rather than do nothing at all (Said et al., 2014).

     Numerous invasive and noninvasive diagnostic tests have been developed. Each of the techniques has advantages as well as disadvantages which will make it more or less appropriate depending on the clinical situation. It is now clear that the discussion over the different diagnostic methods cannot be oversimplified by reasoning only in term of which is the best diagnostic tool (Best et al., 2018).

     The choice of diagnostic tests to determine H. pylori infection status depends on the sensitivity, specificity, reproducibility, availability, and rapidity of the results as well as the cost of the tests (Ramis, 2017).

     The aim of his study was to compare the diagnostic accuracy of helicobacter pylori antigen in stool with endoscopic finding in patients with upper abdominal symptoms.

PATIENTS AND METHODS

     This is a cross sectional observational study designed to compare the diagnostic accuracy of helicobacter pylori antigen in stool with endoscopic finding in patients with upper abdominal symptoms.

     This study included 150 patients with upper abdominal Complaints referred from outpatient inpatient department at Liver Institute, Al Mahalla Al Kobra, Gharbia Governerate, who had undergone gastric biopsy during upper GI endoscopy for various dyspeptic symptoms like pain abdomen, nausea, vomiting, belching, throat pain, and weight loss.

Inclusion criteria: Both sexes will be included, age: 18-60 years, and patients with upper abdominal symptoms.

Exclusion criteria: Age below 18 or above 60 years, patients on proton pump inhibitor or H2 blocker or prokinetics, patients with drug history of corticosteroids and NSAIDs, and patients with previous operations as cholecystectomy and gastric resection.

     A written informed consent was obtained from all participants before inclusion in the study, explaining the value of the study, plus the procedures that was commenced.

All patients were subjected to the following:

1.   Full history taking including:

•     Demographic data: age, sex, special habits.

•     Medical history: Associated chronic diseases, and state of current disease.

•     Family history and drug history.      

2.   Clinical examination: General examination: Vital signs (Blood pressure, pulse, respiratoryrate, temperature), and abdominal examination.

3.   Laboratory measurements: including CBC and serum antigens of H. Pylori.

4.   H. pylori stool antigen test (Moon et al., 2018):

•     Specimen collection: Fresh stool samples were collected and were stored at –70ºC for analysis. H. pylori antigen was analyzed using the SD H. pylori antigen ELISA kit (Standard Diagnostics Inc., Yongin, Korea) according to the manufacturer’s instructions.

•     Technique:

-     Fecal samples were diluted with diluent, and were added with controls and a peroxidase- conjugated monoclonal antibody. After the addition, incubated for an hour at 37ºC. Washing was done to remove unbound materials. After washing, substrate was added and sent for 10 minutes of incubation. The results were read using a spectrophotometer at 450 nm. Negative result was given when the optical density (OD) of stool H. pylori antigen was ≤ the negative mean OD +0.1. Positive result was subclassified into two findings. Strongly positive result was given when OD of stool H. pylori antigen was ≥ 3.0, and a weakly positive result was given when OD was between the mean negative OD +0.1 and 3.0.

5.   Abdominal ultrasonography using real time scanning device Toshiba, just vision 200 (SSA, 320A) with convex probe, 3-5uHz to assess the state of liver, spleen, kidneys and any other abdominal organs.

6.   Upper GIT endoscopy and biopsy Technique (Lee et al., 2015)

•     Sedation: Propofol was used for a sedated endoscopy, is effective in preventing vomiting and relaxing the upper esophageal sphincter (UES).

•     Posture: Examinee (patient): The basic posture was the left lateral decubitus position, (or if they experience difficulty lying in that manner, they can be examined in the supine position). Examiner (endoscopist): EGD was performed using the one-man standing method because it is faster.

•     The endoscopic diagnosis was categorized into GERD, erosions and ulcers.

•     If two or more diagnosis were present in a patient, the severest form of disease was recorded.

•     The biopsy specimens were usually taken from the antrum and other location if required and sent for histological examination.

•     The biopsy specimens were fixed overnight in 10% buffered formalin, processed, embedded in paraffin, and cut and stained with Hematoxylin and Eosin (H &E) and Giemsa stain.

Statistical analysis:

     The collected data were coded, processed and analyzed using the SPSS (Statistical Package for Social Sciences) version 22 for Windows® (SPSS Inc, Chicago, IL, USA). Data were tested for normal distribution using the Shapiro Walk test. Qualitative data were represented as frequencies and relative percentages. Chi square test (χ2) and Fisher exact was used to calculate difference between qualitative variables as indicated. Quantitative data were expressed as mean ± SD (Standard deviation). Independent samples t-test was used to compare between two independent groups of normally distributed variables while Mann Whitney U test was used for non- normally distributed Data. P value < 0.05 was considered significant.

     Validity of stool antigen test as compared with histopathological analysis was expressed by the following terms: Sensitivity = true positive/true positive + false negative. i.e the ability of the test to detect positive cases. Specificity = true negative/true negative + false positive. i.e the ability of the test to exclude negative cases. Validity= true positive + true negative/all examined. Positive predictive value (PPV) = true positive/true positive + false positive. Negative predictive value (NPV) = true negative/true negative + false negative.


 

 

 

 

 

 

 

 

 

 

RESULTS

 

 

     The mean age of the include cases was 37.10 years (range, 15-60). When dividing cases according to age group, most of the cases (46.7%) were between the age of 20 and 40. Eighty four males (56%) and 66 females (44%) were included. Urban residence was reported by 60.7% of cases, while the remaining cases were having rural residence. Secondary education level was the most common educational level encountered in our cases (64 cases - 42.7%), followed by high education (47 - 31.3%). Farmers were the commonest occupation encountered in our study (58 cases – 38.7%), followed by students (37 cases – 24.7%). Housewives have the least distribution in our study (15 cases – 10%). Tap water was the commonest drinking source in this study (91 – 60.7%), followed by ground water (27 cases – 18%) (Table 1).


 

Table (1): Demographic data of the cases of the study

Items

Study cases

n=150

Age (years)

Mean ± SD

33.10 ± 11.28

Median (min-max)

36 (15-60)

Age groups

< 20 years

23 (15.3%)

20-29 years

36 (24%)

30-39 years

34 (22.7%)

40-49 years

30 (20%)

50-60 years

27 (18%)

Sex

Male

84 (56%)

Female

66 (44%)

Residence

Urban

91 (60.7%)

Rural

59 (39.3%)

Education level

Not educated

16 (10.7%)

Primary level

23 (15.3%)

Secondary level

64 (42.7%)

High educational level

47 (31.3%)

Occupation

Housewives

15 (10%)

Students

37 (24.7%)

Office work

22 (14.7%)

Farmer

58 (38.7%)

Manual work

18 (12%)

Source of drinking water

Tap water

91 (60.7%)

River

14 (9.3%)

Ground water

27 (18%)

Bottles water (spring water)

18 (12%)

       

Continuous data expressed as mean±SD and median (range) Categorical data expressed as Number (%).

 

     Ultrasound revealed no abnormality in 95 cases in this study (63.3%). Early cirrhotic liver was detected in 5 cases (3.3%), while marked cirrhosis was present only in one case (0.7%). Gall stones were detected in 15 cases (10%) while 2 cases were having bilateral renal gravels (1.3%). Enlarged prostate was found in 6 cases (4%) (Table 2).

 

 

Table (2):  Ultrasonographic findings of the cases of the study

 

Frequency (n=150)

Percent (%)

NAD

95

63.3

Liver

Bright liver

8

5.4

Cirrhotic liver

1

0.7

Early cirrhotic liver

5

3.3

Fatty liver

2

1.3

Gall bladder

Chronic calcular cholecystitis

15

10

Spleen

Moderate splenomegaly

1

0.7

Urinary system

Bilateral renal gravels

2

1.3

Bilateral increase in renal parenchyma

1

0.7

Cystitis

2

1.4

Left renal stone with back pressure

1

0.7

Left renal stone with no back pressure

1

0.7

Left renal tiny stones

1

0.7

Right hydronephrosis

1

0.7

Right renal gravels

1

0.7

Right renal stone

2

1.3

Simple right renal cyst

1

0.7

Other

Enlarged prostate

6

4.0

Right ovarian simple cyst

1

0.7

Left simple ovarian cyst

2

1.3

Bilateral ovarian simple cyst

1

0.7

Thick endometrium

1

0.7

Total

150

100

 

 

 

 

 

 

 

 

 

 

 

 

     The most common presenting symptom was dyspepsia (53 cases – 39.3%), followed by epigastric pain (53 cases – 35.5%). Abdominal fullness was reported in 15 cases (10%). The presentations included heart burn, abdominal distension, abdominal pain, and nausea (Table 3).

 

 

Table (3):  Analysis of the presenting symptoms in the cases in the study

 

Frequency

Percent

Heart burn

10

6.7

Abdominal distention

1

0.7

Abdominal fullness

15

10

Abdominal pain

6

4

Dyspepsia

60

40

Epigastric pain

53

35.3

Persistent nausea

5

3.3

Total

150

100

 

 

     Endoscopy revealed no abnormality in 29 cases (19.3%). The most common encountered finding was mosaic antral appearance. Antral erosions were diagnosed in 15 cases (10%) whereas erosive gastritis was present in 13 cases (8.6%) (Table 4).

 

 

Table (4):  Analysis of findings of endoscopy

 

Frequency

Percent

NAD

29

19.3

Antral erosions

15

10

Bulb duodenitis

3

2

Duodenal superficial clean ulcer

7

4.7

Erosive duodenitis

6

4.0

Erosive gastritis

13

8.6

GERD class A

4

2.7

GERD grade B, OVS grade I, PHG

1

0.7

lesser curvature superficial clean ulcer

1

0.7

Lower esophagitis

4

2.7

Mosaic appearance of the antrum

47

31.3

Multiple prepyloric antral inflammatory polyps

2

1.3

Multiple prepyloric antral ulcerations

1

0.7

Non erosive gastritis

8

5.3

Prepyloric antral erosions

3

2

Prepyloric small multiple ulcerations

4

2.7

Sliding H.H

2

1.3

Total

150

100

 

 

 

 

 

 

 

 

     The stool antigen test revealed 65.8% sensitivity, 60% specificity, 64.4% accuracy, 86.8% PPV and 30.5% NPV in prediction of symptoms. The stool antigen test revealed 75% sensitivity, 71.7% specificity, 74% accuracy, 85.7% PPV and 55.9% NPV in prediction of endoscopic findings (Table 5).

 

 

Table (5):  Correlation between results of stool antigen test and symptoms and endoscopic findings

Symptoms

Stool antigen test

Negative (N=59)

Positive (N=91)

Negative

18 (30.5%)

12 (13.2%)

Positive

41 (69.5%)

79 (86.8%)

Sensitivity

65.8%

Specificity

60%

Accuracy

64.7%

PPV

86.8%

NPV

30.5%

Endoscopic findings

 

Negative

33 (55.9%)

13 (14.3%)

Positive

26 (44.1%)

78 (85.7%)

Sensitivity

75%

Specificity

71.7%

Accuracy

74%

PPV

85.7%

NPV

55.9%

PPV: positive predictive value NPV: negative predictive value

 

 

     The CLO test revealed 68.3% sensitivity, 46.7% specificity, 64% accuracy, 83.7% PPV and 26.9% NPV in prediction of symptoms. The CLO test revealed 73.1% sensitivity, 52.2% specificity, 66.7% accuracy, 77.6% PPV and 46.2% NPV in prediction of endoscopic findings (Table 6).

 

 

Table (6):  Correlation between results of CLO test and symptoms and Endoscopic findings

Symptoms

CLO test

Negative (N=52)

Positive (N=98)

Negative

14 (26.9%)

16 (16.3%)

Positive

38 (73.1%)

82 (83.7%)

Sensitivity

68.3%

Specificity

46.7%

Accuracy

64%

PPV

83.7%

NPV

26.9%

Endoscopic findings

 

Negative

24 (46.2%)

22 (22.4%)

Positive

28 (53.8%)

76 (77.6%)

Sensitivity

73.1%

Specificity

52.2%

Accuracy

66.7%

PPV

77.6%

NPV

46.2%

PPV: positive predictive value NPV: negative predictive value

 

     As compared with results of biopsies, stool antigen test revealed 77.8 % sensitivity, 90 % specificity and total validity of 85%. With high significant level of agreement between the two techniques (p < 0.001) (Table 7).

 

 

Table (7):  Analysis of the validity of stool antigen test against as compared to histopathology

Stool antigen

test

Biopsy results

Measure of agreement

Kappa

P value

Absent (35)

Present (115)

0.722

< 0.001**

Absent

35 (100%)

24 (20.9%)

Present

0 (0%)

91 (79.1%)

Sensitivity

77.8%

Specificity

90%

Accuracy

85%

PPV

90%

NPV

64.3%

** = highly statistically significant

 

 

DISCUSSION

     In this study, the mean age of the include cases was 37.10 years (range, 15-60). Eighty four males (56%) and 66 females (44%) were included.

     Similar results were reported by Srinivasan et al. (2016) who showed that of the 479 patients evaluated, males were 278 (58%) and females were 201 (42%).

     Seid et al. (2018) reported that during the study period a total of 363 (57.3% females) with upper gastrointestinal symptomatic adults who fulfilled the inclusion criteria were included in the analysis. The age of participants ranged from 18 to 85 years with a mean (± SD) of 39.11 ±15.38 years.

     In another study, the sample included 100 patients, 54% were males and 46% were females, giving a male to female ratio of 1.2:1. The age ranged from 20 - 49 years with a mean of 34.2 ± 8.5 years (Mohammed, 2014).

     In this study, when dividing cases according to age group, most of the cases (46.7%) were between the age of 20 and 40 which probably reflects the acquisition of the infection during adulthood period.

     Our data did coincided with most published studies conducted previously, in which prevalence is seen to rise until it peaks in middle- aged individuals, around 50-60 years (Zhang et al., 2010 and Dhakhwa et al., 2012).

     In this study, urban residence was reported by 60.7% of cases, while the remaining cases were having rural residence. Secondary education level was the most common educational level encountered in our cases (64 cases - 42.7%), followed by high education (47 - 31.3%).

     Also, farmers were the commonest occupation encountered in our study (58 cases – 38.7%), followed by students (37 cases – 24.7%). Housewives have the least distribution in our study (15 cases – 10%). Tap water was the commonest drinking source in this study (91 – 60.7%), followed by ground water (27 cases – 18%).

     This came in agreement with another study where majorities, 38.3%, of the participants do not have formal education and 42.1% were farmer. Two hundred eight (57.3%) of total participants were rural residents, and 61.4% of participants had used tap water for their daily consumption (Seid et al., 2018).

     Also in the study conducted by Adu-Aryee et al. (2016) reported that a vast majority of the study subjects (88.2 %, n = 67) were from urban areas and 9 (11.8 %) were from rural areas.

     In this study, Stool antigen test was positive in 91 cases (60.7%). Moreover, CLO test was positive in 98 cases (65.3%).

     Similar results were reported by Seid et al. (2018) who reported that among 363 participants, H. pylori IgG were detected in 225 (70.25%) participants.

     The overall prevalence of H. pylori infection in another study was 68% (155/228) among symptomatic patients referred for endoscopies in our local setting (Shrestha et al., 2019).

     Srinivasan et al. (2016) showed that 248 (51.7%) of the 479 patients were found to be H pylori positive. While Moon et al. (2018) showed that of the 318 included subjects, stool test was positive in 256 (80.5%).

     In this study, endoscopy revealed no abnormality in 29 cases (19.3%). The most common encountered finding was mosaic antral appearance. Antral erosions were diagnosed in 15 cases (10%) whereas erosive gastritis was present in 13 cases (8.6%).

     In the study conducted by Mohammed (2014), the commonest osephageogastro duodenoscopy (OGD) findings were antral gastropathy (59%) and duodenal ulcer (21%).

     In accordance with the current results, Srinivasan et al. (2016) reported that gastritis at 59.4% was the most common endoscopic finding in the study population. 61.4% of males and 38.6% of females had gastritis. Esophagitis was seen in 5.2% followed by duodenal ulcer and gastroduodenitis which was seen in 3.1% of patients. 97(20.2%) of patients had normal endoscopy with no mucosal lesions and it was more common in the patients <20 years.

     The most common endoscopic finding in 318 seropositive subjects was chronic atrophic gastritis (CAG). Eleven subjects showed normal endoscopic finding, whereas 79 had more than two diagnoses that included synchronous CAG and metaplastic gastritis (MG) (Moon et al., 2018).

     Endoscopy finding was divided into gastritis, duodenitis, duodenal ulcer, gastric ulcer, and gastric cancer, which was diagnosed in 144 (63.2%), 26 (11.4%), 28 (12.3%), 25 (11%), and 5 (2.2%) patients, respectively (Shrestha et al., 2019).

     Based on previous prevalence studies, it has been established that the finding of a non-bleeding duodenal ulcer has a positive predictive value of over 90 % for H. pylori diagnosis, making confirmatory tests not mandatory. However, the positive predictive values for gastric ulcers, bleeding duodenal ulcers and perforated duodenal ulcers are lower and confirmatory tests would be necessary (Adu-Aryee et al., 2016).

     In the current study, the most common presenting symptom was dyspepsia (53 cases – 39.3%), followed by epigastric pain (53 cases – 35.5%). Abdominal fullness was reported in 15 cases (10%). The presentations included heart burn, abdominal distension, abdominal pain, and nausea in lower frequencies.

     Srinivasan et al. (2016) reported similar results as they showed dyspepsia (67.4%) was the most common symptoms altogether and it was the main presenting complaint amongst males (56.6%) and was more common in the fourth decade. The second most common symptom was pain abdomen which accounted for 14.4% of all patients studied of which 56.5% were males and 43.3% were females.

     In this study, Males represented 62.7% and 51.6% of cases in both groups respectively with no significant difference between the two groups (p = 0.254).

     There were no differences in age and gender between the negative and positive stool test groups (Moon et al., 2018).

     Our results also agreed with Mandal et al. (2019) who showed that of 27 (23.9%) patients infected by H. pylori; 17 (63%) were male and 10 (37%) were female. The infection by H.pylori did not differ significantly between males and females.

     In this study, the presenting symptom was significantly different between the study groups (p = 0.023). With regard to the endoscopic findings, chronic atrophic gastritis (CAG) was more common in those with a positive stool test (p = 0.009) and, chronic superficial gastritis (CSG) was more common in those with a negative stool test (Moon et al., 2018).

     In this study, biopsy findings were positive in 115 (76.7%) cases and negative in 35 (23.3%) cases. As compared with results of biopsies, stool antigen test revealed 77.8 % sensitivity, 90 % specificity and total validity of 85%. With high significant level of agreement between the two techniques (p < 0.001).

     This came in accordance with Mandal et al. (2019) who showed that histopathological finding of chronic active gastritis (CAG) was observed in H. pylori infection. Patients who had H. pylori had significantly higher CAG (85.2%) as compared to H. pylori negative subjects.

     In another study, comparing the stool antigen with antral histological examination as gold standard for diagnosis of H. pylori infection revealed 65.2 % sensitivity, 46.8% specificity and total accuracy of 60.4% respectively which were lower than the results of our study (Mohammed, 2014).

     In another study, the most common endoscopic findings was erythematous antral gastritis (40.7%) followed by erosive gastritis 34 (30.1%), pangastritis 10 (8.8%), duodenal ulcer 13 (11.5%), gastric ulcer 9 (8%) and erosive fundal gastritis 2 (1.8%) were detected. The endoscopic findings such as gastritis, gastric ulcer, duodenal ulcer were not significantly associated with H. pylori. Ten (37%) reflux esophagitis patients were H. pylori infected (Mandal et al., 2019).

 

 

CONCLUSION

     Dyspepsia is the common presentation among cases complaining from upper GIT symptoms.

     Most of the cases were positive for H. pylori antigens indicating high prevalence among cases with upper GIT symptoms.

     Most of the cases with upper GIT symptoms had benign pathology on histopathological analysis.

     Stool antigen test for H. Pylori revealed high sensitivity in comparison with histopathological findings in diagnosis cases with upper GIT symptoms.

REFERENCES

  1. Adu-Aryee N, Aabakken L, Dedey F, Nsaful J and Kudzi W. (2016): Comparison of endoscopic based diagnosis with Helicobacter urease test for Helicobacter pylori infection. BMC Research Notes, 9(1): 421-426.
  2. Best LM, Takwoingi Y, Siddique S, Selladurai A, Gandhi A and Low B. (2018): Non‐invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database of Systematic Reviews, 3: 116-121.
  3. Dhakhwa R, Acharya I, Shrestha H, Joshi D, Lama S and Lakhey M. (2012): Histopathologic study of chronic antral gastritis. Journal of Nepal Health Research Council, 12: 45-51.
  4. Diaconu S, Predescu A, Moldoveanu A, Pop C and Fierbințeanu-Braticevici C. (2017): Helicobacter pylori infection: old and new. Journal of Medicine and Life, 10(2): 112-117.
  5. Mandal AK, Kafle P, Puri P, Chaulagai B, Sidhu JS and Hassan M. (2019): An association of Helicobacter pylori infection with endoscopic and histological findings in the Nepalese population. Journal of Family Medicine and Primary Care, 8(3): 1227-32.
  6. Mohammed MO. (2014): Correlation of endoscopic findings with various helicobacter pylori tests among dyspeptic patients. International Journal of Clinical Medicine, 5(19): 1180-84.
  7. Moon HW, Lee SY, Hur M and Yun YM. (2018): Characteristics of Helicobacter pylori-seropositive subjects according to the stool antigen test findings: a prospective study. The Korean Journal of Internal Medicine, 33(5): 893-97.
  8. Ramis IB. (2017): Molecular methods for detection of Helicobacter pylori infection: could they be the gold standard? . Jornal Brasileiro de Patologia e Medicina Laboratorial, 53(1): 4-9.
  9. Riddle MS, DuPont HL and Connor BA. (2016): ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. The American Journal of Gastroenterology, 111(5): 602-607.
  10. Said EM, Abdelkarim MY, Fudl AA, Barakat S and Abdu AE. (2014): A New Horizon for Gastrointestinal Endoscopy in Port Sudan, Sudan: Through Concept, Design and Delivery? A Visiting Practitioner’s Commentary. Global Journal of Gastroenterology & Hepatology, 2(1): 35-40.
  11. Seid A, Tamir Z, Kasanew B and Senbetay M. (2018): Co- infection of intestinal parasites and Helicobacter pylori among upper gastrointestinal symptomatic adult patients attending Mekanesalem Hospital, northeast Ethiopia. BMC Research Notes, 11(1): 144-147.
  12. Shrestha UK, Ghosh A, Alurkar VM, Kohli SC and Sapkota S. (2019): Prevalence of Helicobacter pylori infection, its correlation with gastroduodenal diseases and the incidence of gastric cancer in Nepal. Journal of Advances in Internal Medicine, 2(2): 52-60.
  13. Srinivasan S, Thomas S, Kurpad R, Muddegowda PH, Lingegowda JB and Rajan C. (2016): Correlating Upper GI Symptoms and Endoscopic Findings with H Pylori Positivity–A Rural Tertiary Care Perspective. JMSCR, 10: 13010-13019.
  14. Talley NJ. (2017): Functional dyspepsia: advances in diagnosis and therapy. Gut and Liver, 11(3): 349-55.
  15. Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T and Matsukura N. (2010): Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World Journal of Gastroenterology, 11(6): 791-796.


معامل الهيليکوباکتر بيلوري في البراز وموجودات المناظير في المرضي بأعراض الجهاز الهضمي العلوي المستمرة

ياسر أبو السعود محمد، إيمان أحمد رويشة، السيد ثروة، محمود حلمي علام

قسم أمراض الکبد والجهاز الهضمي بمعهد الکبد القومي، جامعة المنوفية

E-mail: yasser-abouelsoud2326@gmail.com

خلفية البحث: بکتيريا المَلوية البَوابية هي مصدر قلق کبير اليوم بسبب علاقتها السببية بمرض المعدة والاثني عشر. يعاني نصف سکان العالم من عدوى الملوية البوابية، مع انتشار يقدر بأکثر من 90٪ في البلدان النامية. يعد عسر الهضم شکوى منتشرة في عيادات الممارسة العامة والجهاز الهضمي. منذ اکتشافه وعُزيت الحلزونية البوابية إلى کونها مسؤولة عن العديد من أعراض الجهاز الهضمي العلوي. الاختبار المعياري الذهبي للتشخيص هو تنظير الجهاز الهضمي العلوي مع الخزعة ، ولکنه غير متوفر في جميع مرافق الرعاية الصحية بجانب طبيعته الغازية التي لا يقبلها العديد من المرضى.

الهدف من البحث: مقارنة الدقة التشخيصية لمستضد المَلوية البَوابية في البراز مع الکشف بالمنظار في المرضى الذين يعانون من أعراض أعلى البطن.

المرضى والطرق: تضمنت هذه الدراسة 150 مع شکاوى من الجزء العلوي من البطن محولة من العيادات الخارجية وکذلک قسم المرضى الداخليين الذين خضعوا لخزعة المعدة أثناء تنظير الجهاز الهضمي العلوي لأعراض عسر الهضم المختلفة. تم تجنيد الحالات من معهد الکبد، المحلة الکبرى، محافظة الغربية، مصر.

نتائج البحث: فيما يتعلق بأعراض التقديم، کان عسر الهضم أکثر الأعراض شيوعاً (53 حالة - 39.3٪)، يليه الألم الشرسوفي (53 حالة - 35.5٪). تم الإبلاغ عن امتلاء البطن في 15 حالة (10٪). وکان إختبار مستضد البراز موجبًا في 91 حالة (60.7٪). وکان إختبار الکائن الحي الشبيه بالعطيفة (CLO) موجبًا في 98 حالة (65.3٪). وأظهر التنظير عدم وجود شذوذ في 29 حالة (19.3٪). کان الاکتشاف الأکثر شيوعًا هو المظهر الفسيفسائي الغار. تم تشخيص تآکل الغشاء في 15 حالة (10٪) بينما کان التهاب المعدة التآکلي موجوداً في 13 حالة (8.6٪). وکانت نتائج الخزعة إيجابية في 115 حالة (76.7٪) وسلبية في 35 (23.3٪) حالة. مقارنة بنتائج الخزعات ، أظهر اختبار مستضد البراز حساسية 77.8٪ وخصوصية 90٪ وصلاحية کلية 85٪، مع مستوى عالٍ من التوافق بين الطريقتين.

الاستنتاج: عسر الهضم هو العرض الشائع بين الحالات التي تشکو من أعراض الجهاز الهضمي العلوي. أظهر إختبار مستضد البراز لجرثومة المَلوية البَوابية حساسية عالية بالمقارنة مع نتائج التشريح المرضي في حالات التشخيص بأعراض الجهاز الهضمي العلوي.

الکلمات الدالة: بکتيريا المَلوية البَوابية، مستضد البراز، نتائج التنظير الداخلي، الجزء العلوي من البطن.

  1. REFERENCES

    1. Adu-Aryee N, Aabakken L, Dedey F, Nsaful J and Kudzi W. (2016): Comparison of endoscopic based diagnosis with Helicobacter urease test for Helicobacter pylori infection. BMC Research Notes, 9(1): 421-426.
    2. Best LM, Takwoingi Y, Siddique S, Selladurai A, Gandhi A and Low B. (2018): Non‐invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database of Systematic Reviews, 3: 116-121.
    3. Dhakhwa R, Acharya I, Shrestha H, Joshi D, Lama S and Lakhey M. (2012): Histopathologic study of chronic antral gastritis. Journal of Nepal Health Research Council, 12: 45-51.
    4. Diaconu S, Predescu A, Moldoveanu A, Pop C and Fierbințeanu-Braticevici C. (2017): Helicobacter pylori infection: old and new. Journal of Medicine and Life, 10(2): 112-117.
    5. Mandal AK, Kafle P, Puri P, Chaulagai B, Sidhu JS and Hassan M. (2019): An association of Helicobacter pylori infection with endoscopic and histological findings in the Nepalese population. Journal of Family Medicine and Primary Care, 8(3): 1227-32.
    6. Mohammed MO. (2014): Correlation of endoscopic findings with various helicobacter pylori tests among dyspeptic patients. International Journal of Clinical Medicine, 5(19): 1180-84.
    7. Moon HW, Lee SY, Hur M and Yun YM. (2018): Characteristics of Helicobacter pylori-seropositive subjects according to the stool antigen test findings: a prospective study. The Korean Journal of Internal Medicine, 33(5): 893-97.
    8. Ramis IB. (2017): Molecular methods for detection of Helicobacter pylori infection: could they be the gold standard? . Jornal Brasileiro de Patologia e Medicina Laboratorial, 53(1): 4-9.
    9. Riddle MS, DuPont HL and Connor BA. (2016): ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. The American Journal of Gastroenterology, 111(5): 602-607.
    10. Said EM, Abdelkarim MY, Fudl AA, Barakat S and Abdu AE. (2014): A New Horizon for Gastrointestinal Endoscopy in Port Sudan, Sudan: Through Concept, Design and Delivery? A Visiting Practitioner’s Commentary. Global Journal of Gastroenterology & Hepatology, 2(1): 35-40.
    11. Seid A, Tamir Z, Kasanew B and Senbetay M. (2018): Co- infection of intestinal parasites and Helicobacter pylori among upper gastrointestinal symptomatic adult patients attending Mekanesalem Hospital, northeast Ethiopia. BMC Research Notes, 11(1): 144-147.
    12. Shrestha UK, Ghosh A, Alurkar VM, Kohli SC and Sapkota S. (2019): Prevalence of Helicobacter pylori infection, its correlation with gastroduodenal diseases and the incidence of gastric cancer in Nepal. Journal of Advances in Internal Medicine, 2(2): 52-60.
    13. Srinivasan S, Thomas S, Kurpad R, Muddegowda PH, Lingegowda JB and Rajan C. (2016): Correlating Upper GI Symptoms and Endoscopic Findings with H Pylori Positivity–A Rural Tertiary Care Perspective. JMSCR, 10: 13010-13019.
    14. Talley NJ. (2017): Functional dyspepsia: advances in diagnosis and therapy. Gut and Liver, 11(3): 349-55.
    15. Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T and Matsukura N. (2010): Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World Journal of Gastroenterology, 11(6): 791-796.